VA patient first to receive groundbreaking epilepsy treatment

A veteran treated at the Michael E. DeBakey VA Medical Center in Houston has become the first patient in the entire VA healthcare system to receive a minimally invasive laser treatment for epilepsy. Robert Lindemann, who served nearly 33 years in the Army National Guard before retiring as a commissioned officer, underwent the groundbreaking procedure using technology called Visualase V2, marking a significant expansion in neurosurgical capabilities available to veterans across the country.

Lindemann's journey to this historic procedure began after he was diagnosed with focal epilepsy following years of unexplained episodes where he would lose time and feel disconnected from his surroundings. After trying numerous medications without success, he was referred to the epilepsy center of excellence at the Houston facility, where testing revealed his seizures originated deep in his right temporal lobe. The traditional treatment would have required a craniotomy, an invasive open brain surgery to remove a large portion of his temporal lobe, a prospect Lindemann understandably found frightening.

The Visualase V2 system represents a dramatic departure from conventional brain surgery for focal epilepsy. Dr. Garrett Banks, the neurosurgeon who performed the procedure, explained that the technology delivers extremely precise laser ablation through a slender fiber optic catheter inserted through a hole in the skull just 3.2 millimeters wide, smaller than a pencil eraser. Real-time MRI guidance allows surgeons to monitor tissue temperatures moment by moment, making immediate adjustments to protect surrounding brain structures while precisely targeting the problem tissue. Lindemann was discharged just two days after the procedure and reported feeling great within four days.

This advancement matters particularly for veterans with focal epilepsy, deep brain tumors, or radiation necrosis who previously faced only the option of invasive open surgery with its associated risks, lengthy recovery periods, and potential cognitive impacts. While the Visualase technology has been used at a limited number of leading academic epilepsy centers, it had never been available at any VA facility until now. The successful implementation at the Houston medical center opens the door for this treatment to become available to veterans at other VA facilities nationwide.

For disabled veterans, this development represents more than just a new surgical option. It reflects VA's commitment to bringing cutting-edge medical technology into its healthcare system, ensuring veterans have access to the same advanced treatments available at top civilian medical centers. The preservation of cognitive abilities and faster recovery times are especially critical for veterans already managing service-connected disabilities, as invasive brain surgery could compound existing challenges with daily functioning, employment, and quality of life.

Veterans currently being treated for epilepsy through VA healthcare should discuss their treatment options with their VA neurologist or primary care provider, particularly if current medications are not adequately controlling seizures. Those who have been told they are candidates for traditional epilepsy surgery may want to ask specifically about minimally invasive alternatives like laser ablation. Veterans not currently enrolled in VA healthcare but experiencing seizures or other neurological symptoms should contact their nearest VA medical center to explore eligibility for enrollment and specialized neurology services, as early intervention and proper diagnosis remain essential for effective treatment of epilepsy and related conditions.